§329-59  Controlled substance registration revolving fund; established.  (a)  [Subsection effective until December 31, 2023.  For subsection effective January 1, 2024, see below.]  There is established within the state treasury the controlled substance registration revolving fund.  The fund shall be expended at the discretion of the director of public safety for the purpose of:

     (1)  Offsetting the cost of the electronic prescription accountability system, investigation of violations of this chapter, the registration and control of the manufacture, distribution, prescription, and dispensation of controlled substances and regulated chemicals listed under section 329-61, within the State;

     (2)  Funding positions authorized by the legislature by law; and

     (3)  Funding the narcotics enforcement division's forensic drug laboratory facility.

     (a)  [Subsection effective January 1, 2024.  For subsection effective until December 31, 2023, see above.]  There is established within the state treasury the controlled substance registration revolving fund.  The fund shall be expended at the discretion of the director of law enforcement for the purpose of:

     (1)  Offsetting the cost of the electronic prescription accountability system, investigation of violations of this chapter, the registration and control of the manufacture, distribution, prescription, and dispensation of controlled substances and regulated chemicals listed under section 329-61, within the State;

     (2)  Funding positions authorized by the legislature by law; and

     (3)  Funding the narcotics enforcement division's forensic drug laboratory facility.

     (b)  The fund shall consist of all moneys derived from fees collected pursuant to sections 329-31 and 329-67 and legislative appropriations.  All fees collected pursuant to sections 329-31 and 329-67 shall be deposited in the controlled substance registration revolving fund. [L 1996, c 268, §3; am L 1999, c 252, §6; am L 2002, c 165, §5; am L 2008, c 119, §2; am L 2013, c 177, §3; am L 2022, c 278, §17]